David Shook - 04 Jan 2024 Form 4 Insider Report for Nkarta, Inc. (NKTX)

Role: Chief Medical Officer
Signature: /s/ Alicia Hager, as Attorney-in-Fact
Issuer symbol: NKTX
Transactions as of: 04 Jan 2024
Net transactions value: $0
Form type: 4
Filing time: 08 Jan 2024, 16:50:43 UTC
Previous filing: 23 Aug 2023
Next filing: 18 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NKTX	Common Stock	Award	$0	+56,000	+90%	$0.000000	118,532	04 Jan 2024	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NKTX	Stock Option (right to buy)	Award	$0	+112,500		$0.000000	112,500	04 Jan 2024	Common Stock	112,500	$6.01	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on January 14, 2025. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
F2	Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on November 30, 2023.
F3	This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2024.